BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31686638)

  • 1. Advances on the Bioactivities, Total Synthesis, Structural Modification, and Structure-Activity Relationships of Cytisine Derivatives.
    Huang X; Xu H
    Mini Rev Med Chem; 2020; 20(5):369-395. PubMed ID: 31686638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aza-Michael reaction of 12-N-carboxamide of (-)-cytisine under high pressure conditions.
    Tsypysheva IP; Lobov AN; Kovalskaya AV; Petrova PR; Ivanov SP; Rameev SA; Borisevich SS; Safiullin RL; Yunusov MS
    Nat Prod Res; 2015; 29(2):141-8. PubMed ID: 25330752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
    Chellappan SK; Xiao Y; Tueckmantel W; Kellar KJ; Kozikowski AP
    J Med Chem; 2006 May; 49(9):2673-6. PubMed ID: 16640326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors.
    Pérez EG; Méndez-Gálvez C; Cassels BK
    Nat Prod Rep; 2012 May; 29(5):555-67. PubMed ID: 22367109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrine: Bioactivities and Structural Modifications.
    Huang J; Xu H
    Curr Top Med Chem; 2016; 16(28):3365-3378. PubMed ID: 27150374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiviral evaluation of cytisine derivatives against dengue virus types 1 and 2.
    Tsypysheva IP; Lai HC; Kiu YT; Koval'skaya AV; Tsypyshev DO; Huang SH; Lin CW
    Bioorg Med Chem Lett; 2021 Dec; 54():128437. PubMed ID: 34737087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Search of (-)-Cytisine Derivatives as Potential Inhibitors of NF-κB and STAT1].
    Vakhitova YV; Farafontova EI; Zainullina LF; Vakhitov VA; Tsypysheva IP; Yunusov MS
    Bioorg Khim; 2015; 41(3):336-45. PubMed ID: 26502610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A short synthesis of (+/-)-cytisine.
    Botuha C; Galley CM; Gallagher T
    Org Biomol Chem; 2004 Jul; 2(13):1825-6. PubMed ID: 15227532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A flexible strategy for the synthesis of tri- and tetracyclic lupin alkaloids: synthesis of (+)-cytisine, (+/-)-anagyrine, and (+/-)-thermopsine.
    Gray D; Gallagher T
    Angew Chem Int Ed Engl; 2006 Apr; 45(15):2419-23. PubMed ID: 16521145
    [No Abstract]   [Full Text] [Related]  

  • 10. [Research progress on chemical structures and pharmacological effects of natural cytisine and its derivatives].
    Zhou QQ; Xie XY; Zhang YX; Zhou W; Zhan ZJ; Xu JB
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2679-2698. PubMed ID: 37282929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereodirected synthesis of alkaloid-like quinolizidine systems.
    Krasnov KA; Krasnova AA; Kartsev VG; Dorovatovskii PV; Zubavichus YV; Dobrokhotova EV; Kultyshkina EK; Khrustalev VN
    Nat Prod Res; 2020 Jan; 34(2):269-277. PubMed ID: 30417705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolizidine alkaloids derivatives from Sophora alopecuroides Linn: Bioactivities, structure-activity relationships and preliminary molecular mechanisms.
    Li Y; Wang G; Liu J; Ouyang L
    Eur J Med Chem; 2020 Feb; 188():111972. PubMed ID: 31884408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses of (+)-cytisine, (-)-kuraramine, (-)-isokuraramine, and (-)-jussiaeiine A.
    Honda T; Takahashi R; Namiki H
    J Org Chem; 2005 Jan; 70(2):499-504. PubMed ID: 15651792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
    Fitch RW; Kaneko Y; Klaperski P; Daly JW; Seitz G; Gündisch D
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1221-4. PubMed ID: 15686946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.
    Coe JW; Vetelino MG; Bashore CG; Wirtz MC; Brooks PR; Arnold EP; Lebel LA; Fox CB; Sands SB; Davis TI; Schulz DW; Rollema H; Tingley FD; O'Neill BT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):2974-9. PubMed ID: 15908213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3-Oxazole derivatives of cytisine as potential inhibitors of glutathione reductase of Candida spp.: QSAR modeling, docking analysis and experimental study of new anti-Candida agents.
    Metelytsia LO; Trush MM; Kovalishyn VV; Hodyna DM; Kachaeva MV; Brovarets VS; Pilyo SG; Sukhoveev VV; Tsyhankov SA; Blagodatnyi VM; Semenyuta IV
    Comput Biol Chem; 2021 Feb; 90():107407. PubMed ID: 33191110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Cytisine and derivatives: synthesis, reactivity, and applications.
    Rouden J; Lasne MC; Blanchet J; Baudoux J
    Chem Rev; 2014 Jan; 114(1):712-78. PubMed ID: 24117010
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytisine and cytisine derivatives. More than smoking cessation aids.
    Gotti C; Clementi F
    Pharmacol Res; 2021 Aug; 170():105700. PubMed ID: 34087351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core modification of cytisine: a modular synthesis.
    Hirschhäuser C; Haseler CA; Gallagher T
    Angew Chem Int Ed Engl; 2011 May; 50(22):5162-5. PubMed ID: 21520366
    [No Abstract]   [Full Text] [Related]  

  • 20. Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes.
    Carbonnelle E; Sparatore F; Canu-Boido C; Salvagno C; Baldani-Guerra B; Terstappen G; Zwart R; Vijverberg H; Clementi F; Gotti C
    Eur J Pharmacol; 2003 Jun; 471(2):85-96. PubMed ID: 12818695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.